PillRx only · Injection · Intravenous
Gadoterate Meglumine
Brands: Dotarem · Gadoterate Meglumine
3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
3 active makers
3 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)1421144
US makers3 labelers
Packages24
DEA / ScheduleNone
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
55
Rx · 2026 Q1
2.2K
Units dispensed
+38%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it3 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Guerbet LLC | unknown | 13 | SUPPLYING |
| Slate Run Pharmaceuticals, LLC | unknown | 6 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 5 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jun 30, 2026RESOLVEDShortage resolved: Gadoterate Meglumine Injection (Jiangsu Hengrui Pharmaceuticals Co., Ltd.)
Gadoterate Meglumine Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Therapeutic category: Medical Imaging.
- May 21, 2026SHORTAGEDrug shortage: Gadoterate Meglumine Injection (Jiangsu Hengrui Pharmaceuticals Co., Ltd.)
Gadoterate Meglumine Injection — reported in shortage by Jiangsu Hengrui Pharmaceuticals Co., Ltd.. Therapeutic category: Medical Imaging.